Press Releases
Kanuma receives marketing approval in Japan for Treatment of Patients with Lysosomal Acid Lipase Deficiency
Alexion Pharmaceuticals, Inc announced that Japan’s Ministry of Health, Labour and Welfare has approved Kanuma for the treatment of patients of all ages in...
Press Releases
FDA approves new indication for Novartis drug Afinitor® for progressive, nonfunctional GI and lung neuroendocrine tumors
Novartis announced that the United States FDA approved Afinitor® tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors of gastrointestinal...
Press Releases
Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer Antibody-Drug
Mersana Therapeutics and Takeda Pharmaceutical Company Limited announced that they have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate,...
Press Releases
U.S. FDA Accepts Filing Of Cardiovascular Outcomes Data For Jardiance® (Empagliflozin)
The U.S. FDA accepted a supplemental New Drug Application for Jardiance based on cardiovascular risk reduction data from the landmark EMPA-REG OUTCOME® trial. ...
News
FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc announced that the U.S. FDA granted approval for Basaglar 100 units/mL. BASAGLAR is a long-acting...
Production & Manufacturing
Beximco Pharma forms JV with Malaysia-based BioCare Manufacturing
Beximco Pharmaceuticals Limited the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing...
News
Alcon spotlights DAILIES TOTAL1® contact lenses in national television campaign
TV spot showcases the science behind the ultimate breathability and comfort of DAILIES TOTAL1® contact lenses Fort Worth, Texas- Alcon, the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read